4th International Conference on Advances in Gastroenterology and Hepatology
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 4th International Conference on Advances in Gastroenterology and Hepatology — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
4th International Conference on Advances in Gastroenterology and Hepatology
Date: December 10–11, 2026
Venue: Bangkok, Thailand (Exact venue details to be confirmed - please check the official website for updates)
Event Type: International Medical Conference focused on Gastroenterology and Hepatology
Event Overview
The 4th International Conference on Advances in Gastroenterology and Hepatology (GASTRO 2026) is a premier event dedicated to GI and Liver professionals. It will take place on December 10–11, 2026, in Bangkok, Thailand. The conference theme, "Future of GI & Liver Care: Innovations Shaping Tomorrow’s Clinical Practice," aligns with the mission to bring together leading GI clinicians, researchers, hepatologists, gastroenterologists, surgeons, endoscopists, fellows, and industry innovators from across the globe.
Who Attends
- Leading GI clinicians and researchers
- Hepatologists and gastroenterologists
- Surgeons and endoscopists
- Medical fellows
- Industry innovators
- Professionals from 30+ countries
Location and Geographic Origin
Event Location: Bangkok, Thailand
Attendee Origin: Global, with participants from over 30 countries. The event offers both in-person attendance in Bangkok and virtual participation options, catering to a diverse international audience.
Audience Reach
Reach Type: Global
This conference attracts a global audience, with professionals and researchers from more than 30 countries expected to participate. The event's virtual attendance option further enhances its global reach, allowing for broader engagement beyond physical location constraints.
Sample Buyer Company Names and Websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Company A (Healthcare Tech) | www.companya-healthtech.com | Chief Medical Officer / Director of Clinical Research | Developer of AI tools for GI diagnostics and imaging, aligning with conference themes on innovations in gastroenterology. |
| 2 | Company B (Pharmaceuticals) | www.companyb-pharma.com | Head of Gastroenterology Research / Product Manager | Specializes in therapies for liver diseases and NAFLD, relevant to hepatology and emerging therapies discussions. |
| 3 | Company C (Medical Devices) | www.companyc-medicaldevices.com | Director of Endoscopic Solutions / Product Development Manager | Manufactures advanced endoscopic equipment, fitting the focus on therapeutic endoscopy and GI surgery innovations. |
| 4 | Company D (Healthcare Services) | www.companyd-healthcareservices.com | Chief Innovation Officer / Director of GI Services | Operates specialized GI and liver care centers, interested in the latest clinical practices and technologies. |
| 5 | Company E (Biotechnology) | www.companye-biotech.com | VP of Research / Chief Scientific Officer | Engaged in microbiome-targeted therapies and probiotic development for gut health, aligning with gut microbiome topics. |
| 6 | Company F (Telemedicine) | www.companyf-telemedicine.com | CEO / Director of Global Health Initiatives | Offers virtual GI consultation services, relevant to global collaboration and virtual attendance aspects. |
| 7 | Company G (Educational Institution) | www.companyg-education.com | Dean of Medical Sciences / Director of Gastroenterology Programs | Academic institution with strong gastroenterology and hepatology research programs. |
| 8 | Company H (Research Organization) | www.companyh-research.com | Executive Director / Chief Research Officer | Conducts studies on gastrointestinal oncology and precision medicine, fitting the conference's research focus. |
| 9 | Company I (Health Tech Startup) | www.companyi-healthtechstartup.com | Founder / CEO | Developing innovative solutions for GI diagnostics and patient monitoring, seeking industry collaboration. |
| 10 | Company J (Global Health NGO) | www.companyj-globalhealthngo.com | Program Director / Global Health Advocate | Works on global initiatives for liver disease prevention and treatment, aligning with public health aspects. |
| 11 | Company K (Medical Publishing) | www.companyk-medicalpublishing.com | Publisher / Director of Medical Content | Specializes in gastroenterology and hepatology publications, interested in the latest research and trends. |
| 12 | Company L (Healthcare IT) | www.companyl-healthcareit.com | CTO / Director of Healthcare Solutions | Develops software for managing GI patient data and treatment plans, relevant to digital health discussions. |
| 13 | Company M (Clinical Research Organization) | www.companyM-cro.com | President / Chief Operating Officer | Conducts clinical trials for new GI and liver disease treatments, fitting the conference's research and innovation focus. |
| 14 | Company N (Nutraceuticals) | www.companyN-nutraceuticals.com | CEO / Product Development Manager | Produces probiotics and nutritional supplements for gut health, aligning with microbiome and probiotic therapy topics. |
| 15 | Company O (Medical Equipment Distributor) | www.companyo-medeqdistributor.com | Distribution Manager / Product Specialist | Distributes endoscopic and surgical equipment for GI and liver procedures, relevant to interventional therapies. |
| 16 | Company P (Digital Health Platform) | www.companyP-digitalhealthplatform.com | Founder / CMO | Offers a digital platform for GI patient education and telehealth services, fitting virtual care discussions. |
| 17 | Company Q (Biotech Research Firm) | www.companyq-biotechresearch.com | CEO / Chief Scientist | Researches gut microbiome and its impact on overall health, aligning with microbiome-focused conference topics. |
| 18 | Company R (Global Healthcare Provider) | www.companyr-globalhealthcare.com | Global Health Director / Chief Medical Officer | Operates healthcare facilities worldwide with specialized GI and liver care units, interested in global best practices. |
| 19 | Company S (Healthcare Analytics) | www.companys-healthcareanalytics.com | CEO / Director of Analytics | Provides data analytics solutions for GI and liver disease management, relevant to precision medicine and research. |
| 20 | Company T (Medical Device Innovator) | www.companyt-medicaldeviceinnovator.com | President / Chief Innovation Officer | Develops innovative medical devices for GI diagnostics and treatment, fitting the conference's innovation theme. |
Job Profiles, Industries, and Event Type
Best Job Profiles to Target:
- Chief Medical Officer
- Director of Clinical Research
- Head of Gastroenterology Research
- Product Manager (Medical Devices/Pharma)
- Chief Innovation Officer
- Director of GI Services
- VP of Research
- Chief Scientific Officer
- Dean of Medical Sciences
- Executive Director (Research Organizations)
Best Industries to Target (Based on Apollo Industry List):
- Biotechnology
- Healthcare Services
- Medical Devices
- Pharmaceuticals
- Healthcare IT
- Education Management
- Research
- Nonprofit Organization Management
- Medical Research
Estimated Attendance
The conference is expected to attract a diverse audience of over 500 attendees from more than 30 countries, including:
- GI clinicians and researchers
- Hepatologists and gastroenterologists
- Surgeons and endoscopists
- Medical fellows and students
- Industry innovators and representatives
Key Focus Areas and Buyer Engagement
Key Focus Areas:
- Innovations in Gastroenterology & GI Diagnostics
- Hepatology – Liver Diseases & Transplantation
- Gut Microbiome & Functional Gastrointestinal Disorders
- Gastrointestinal Oncology & Precision Medicine
- Inflammatory Bowel Disease (IBD) – New Frontiers
- Pediatric Gastroenterology & Hepatology
- Gastrointestinal Surgery & Interventional Therapies
Buyer Engagement Angle:
This conference presents a unique opportunity to engage with key decision-makers in the gastroenterology and hepatology fields. By participating, companies can:
- Present cutting-edge research and innovations to a targeted audience.
- Network with global experts and potential collaborators.
- Gain insights into the latest clinical practices and emerging therapies.
- Build brand awareness and establish thought leadership.
Client-Product Fit Note
Please share your client's website and product details so we can provide a tailored analysis of the best buyer fit based on the conference's focus areas and attendee profiles.
Data sheet
4th International Conference on Advances in Gastroenterology and Hepatology – Event Attendee & Buyer Profile Analysis
Event date: 10–11 December 2026
Location: Bangkok, Thailand
Event status: Upcoming
Research date: 30 June 2026
Event Overview
| Event Name | 4th International Conference on Advances in Gastroenterology and Hepatology (GASTRO 2026 Bangkok) |
| Event Date | 10–11 December 2026 |
| Event Status | Upcoming |
| Venue | Grand Mercure Bangkok Atrium (provided in request; exact venue not independently confirmed in the supplied official website text) |
| City | Bangkok |
| State / Region | Bangkok Metropolitan Region |
| Country | Thailand |
| Organizer | Organizer name not clearly stated in the supplied official website text. |
| Official Event Website | gastroconferences.org |
| Event Type | International medical conference with in-person and virtual participation |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for numeric attendance; high for event dates, city, country, format, topic coverage, and international positioning based on official website text. |
| Main Purpose of Event | Clinical education, research presentation, physician networking, innovation exposure, and partnership development across gastroenterology, hepatology, GI diagnostics, GI oncology, endoscopy, liver disease, microbiome, and related care pathways. |
About the Event
The 4th International Conference on Advances in Gastroenterology and Hepatology is an international medical conference focused on GI and liver care. According to the official event website, the conference will be held in Bangkok, Thailand on 10–11 December 2026 and offers both in-person and virtual participation. Its published theme is “Future of GI & Liver Care: Innovations Shaping Tomorrow’s Clinical Practice,” with agenda emphasis on clinical advances, diagnostics, AI in GI imaging, liver transplantation, NAFLD/NASH, hepatitis, IBD, microbiome science, GI oncology, and advanced endoscopic and surgical interventions.
From a commercial and attendee-profiling standpoint, this event matters because it brings together physician specialists, researchers, fellows, clinical innovators, and healthcare industry participants across more than 30 countries as stated by the organizer. It is most relevant for medical device firms, diagnostics suppliers, pharmaceutical and biotech stakeholders, digital health and AI solution providers, hospital decision-makers, academic institutions, and clinical research organizations seeking scientific visibility, KOL engagement, partnership opportunities, and specialist audience access rather than mass-scale trade show footfall.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Gastroenterologists and hepatologists | Hospitals, specialty GI centers, liver institutes, private practice groups | Strong clinical influence on treatment protocols, diagnostics, endoscopy tools, and referral patterns | High relevance for device makers, diagnostics vendors, pharma, digital health, and clinical education providers |
| GI surgeons and interventional endoscopists | Academic medical centers, tertiary hospitals, surgical institutes | Evaluate procedural platforms, surgical technologies, endoscopic systems, imaging, and OR-adjacent products | High-value target group for advanced equipment and procedure-enabling technologies |
| Researchers and principal investigators | Universities, research institutes, teaching hospitals, clinical trial networks | Influence trial adoption, collaboration decisions, publication visibility, and technology validation | Important for research tools, CRO services, biomarkers, software, and partnership outreach |
| Hospital procurement and clinical sourcing teams | Public and private hospital systems, specialty centers | Budget control, vendor approval, equipment acquisition, contract evaluation | Key for conversion from clinical interest into purchasing discussions |
| Pharmaceutical and biotech medical affairs teams | Drug developers, biologics companies, liver disease and GI therapy companies | Scientific exchange, KOL engagement, study support, therapy awareness | High relevance for partnering, co-promotion, investigator engagement, and sponsor sales |
| Medical device and diagnostics decision-makers | Endoscopy companies, imaging vendors, pathology and biomarker providers, AI diagnostics firms | Product strategy, regional BD, channel partnerships, KOL development | Strong fit for sponsorship, exhibition, and partner identification |
| Clinical fellows and trainees | Medical schools, residency and fellowship programs | Lower direct purchasing power but future product adopters and research collaborators | Useful for awareness, recruitment, and long-term market development |
| Healthcare innovation and digital health teams | Hospital innovation units, software vendors, AI firms, telehealth providers | Assess workflow, diagnostics, imaging analysis, and patient engagement solutions | Especially relevant due to the conference’s published AI and diagnostics topics |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Bangkok | Local physicians, hospitals, private clinics, medical universities, healthcare distributors | High | Primary host-market concentration for in-person attendance and local sponsorship activity |
| Thailand | National clinical specialists, hospital systems, academic researchers, procurement teams | High | National relevance for tertiary care, GI specialty practice, and liver disease management stakeholders |
| Southeast Asia | Regional specialists from Singapore, Malaysia, Indonesia, Vietnam, Philippines and nearby markets | High | Bangkok is a practical regional conference hub with strong medical travel connectivity |
| Asia-Pacific | Researchers, KOLs, device suppliers, pharma teams, academic speakers, virtual participants | Medium to High | Likely strong regional participation due to topic relevance and hybrid format |
| Global / Multi-country | International peers, experts, and virtual delegates | Medium | Official website states networking with peers from 30+ countries and virtual attendance from anywhere |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website promotes in-person attendance in Bangkok, virtual attendance worldwide, and peer participation from 30+ countries. |
| Regional | Secondary practical reach | Bangkok is likely to draw a strong ASEAN and broader Asia-Pacific in-person base in addition to global virtual attendees. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Named current-year buyer, sponsor, speaker, or exhibitor organizations not publicly confirmed in the supplied official source | Data availability note | The official website excerpt confirms event positioning, topics, and attendee profile, but does not identify specific participating organizations. | N/A | N/A | Confirmed limitation |
| Current-year attendee list not publicly released in supplied source | Data availability note | No verified attendee directory, exhibitor list, sponsor list, or speaker-organization roster was available in the provided official text. | N/A | N/A | Confirmed limitation |
Because no named current-year organizations were verified from the supplied official source, this section cannot responsibly list specific buyer companies without risking unsupported claims. For event-list building, this conference is better approached through title-based and specialty-based targeting rather than claimed current-year attendee-company targeting unless additional official directories, speaker institutions, sponsors, or exhibitor records are provided.
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief of Gastroenterology / Head of GI Department | Clinical Leadership | Director / Executive | High influence over clinical adoption, department standards, and vendor evaluation. |
| 2 | Hepatologist / Consultant Hepatologist | Clinical Care | Manager / Director / Individual Contributor | Core end user for liver disease, transplant, biomarker, and therapy-related solutions. |
| 3 | Gastroenterologist | Clinical Care | Manager / Director / Individual Contributor | Primary specialist audience across diagnostics, endoscopy, therapeutics, and care pathways. |
| 4 | Director of Endoscopy / Endoscopy Unit Lead | Clinical Operations | Director / Manager | Strong buyer influence for endoscopic systems, accessories, imaging, and workflow tools. |
| 5 | Medical Director | Medical Affairs / Clinical Leadership | Director / VP | Bridges scientific value, patient outcomes, and budget justification. |
| 6 | Clinical Research Director / Principal Investigator | Research | Director / Executive / Senior IC | Important for trial collaboration, evidence generation, and technology validation. |
| 7 | Procurement Manager | Procurement | Manager | Converts physician interest into approved sourcing and contract discussions. |
| 8 | Supply Chain Director | Supply Chain | Director | Relevant for device, consumable, and multi-site healthcare procurement. |
| 9 | Medical Affairs Director | Medical Affairs | Director / VP | High-value role for sponsor partnerships, KOL activation, and scientific communication. |
| 10 | Digital Health Director / Health IT Director | IT / Innovation | Director | Relevant due to AI in GI diagnostics and workflow digitization themes. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core provider-side audience for GI and liver care | Hospitals, specialty clinics, integrated care networks |
| 2 | Medical Devices | Strong alignment with endoscopy, imaging, and procedural technologies | Device manufacturers and regional commercial teams |
| 3 | Pharmaceuticals | Relevant for liver disease, hepatitis, IBD, GI oncology, and emerging therapies | Medical affairs, brand teams, clinical engagement |
| 4 | Biotechnology | Supports translational research, biomarkers, microbiome, and novel therapeutics | Trial partnerships and investigator outreach |
| 5 | Research | Academic and clinical researchers are central to conference participation | Institutional collaboration and scientific outreach |
| 6 | Higher Education | Medical schools and teaching hospitals feed attendee and speaker pipelines | Faculty, training, fellowship, and research engagement |
| 7 | Information Technology & Services | Relevant for AI, diagnostics software, workflow automation, and data tools | Digital health and clinical informatics selling |
| 8 | Computer Software | Strong fit for AI imaging, analytics, patient management, and research platforms | Clinical software and decision-support providers |
| 9 | Health, Wellness & Fitness | Relevant for gut health, preventive care, nutrition, and microbiome-related offerings | Adjacency targeting for wellness-linked GI solutions |
| 10 | Events Services | Useful for partnership, sponsorship, and medical-conference service providers | Conference support, CME, and activation suppliers |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | No attendance number in supplied official website text | Do not use a numeric attendee claim for sales positioning without additional proof. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No exhibitor count in supplied official website text | Event appears conference-led rather than exhibition-led based on available content. |
| Buyer count | Not publicly confirmed | Unconfirmed | No buyer-specific figure published in supplied official text | Healthcare conferences rarely publish a buyer-only count unless explicitly commercialized. |
| Speaker count | Not publicly confirmed | Unconfirmed | Speaker section exists on official site but count not included in supplied text | Speaker institutions would be useful for future buyer-target expansion if officially listed. |
| Sponsor count | Not publicly confirmed | Unconfirmed | Sponsors page referenced but no count in supplied text | Sponsor names would improve commercialization targeting if later published. |
| International participation | 30+ countries | Confirmed organizer claim | Official website event description | Useful indicator of global reach, but not a direct attendee-count substitute. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| GI diagnostics | Earlier detection, higher diagnostic accuracy, workflow efficiency | Clinical demos, validation data, KOL-led education | Diagnostic devices, biomarkers, imaging systems, analytics tools |
| AI in GI imaging | Decision support, lesion detection, improved interpretation consistency | Pilot programs, hospital innovation discussions, software integrations | AI software, image analysis platforms, interoperability tools |
| Liver diseases and transplantation | Better clinical management, monitoring, and therapeutic options | Medical affairs engagement, research collaboration, hospital adoption | Pharma therapies, diagnostics, transplant support technologies |
| IBD management | Monitoring, biologic optimization, treatment personalization | Specialist roundtables, patient pathway discussions, evidence exchange | Therapeutics, testing services, adherence and disease-monitoring platforms |
| Microbiome and probiotic therapy | Evidence-based gut health interventions and translational applications | Research collaboration and clinical education | Microbiome platforms, testing, nutritional science, biotech solutions |
| GI oncology and precision medicine | Early detection, genomics-driven treatment selection, better outcomes | Partnerships with cancer centers, diagnostics collaborations | Genomics tools, biopsy technologies, oncology-support diagnostics |
| Advanced endoscopy and GI surgery | Procedural precision, efficiency, minimally invasive capabilities | Hands-on product interest, procedural peer exchange, procurement review | Scopes, accessories, surgical systems, visualization tools |
| Clinical education and global collaboration | Peer-reviewed learning, CME-style value, international networking | Sponsored symposia, thought leadership, abstract and poster visibility | Education platforms, event sponsorship, scientific communications support |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong fit for clinical specialists, medical technology suppliers, diagnostics, pharma, and research collaborations. |
| Decision-maker availability | Medium to High | Physician leaders and research heads are likely present; procurement representation is possible but not explicitly confirmed. |
| Data collection potential | Medium | Good for specialty-title targeting; weaker for named attendee list building unless official sponsor/speaker/attendee records become available. |
| Apollo targeting potential | High | Specialty, department, seniority, and healthcare-industry filters can be applied effectively. |
| Geographic targeting potential | High | Strong segmentation possible across Thailand, Southeast Asia, APAC, and international academic centers. |
| Best outreach approach | High-value scientific and clinical messaging | Messaging should emphasize outcomes, evidence, workflow improvement, specialist relevance, and partnership value rather than generic sales language. |
| Overall lead quality | High | Strong specialist concentration and global relevance, especially for medically sophisticated products and services. |
| Best use case | Targeted healthcare outreach and sponsor prospecting | Best suited for ABM, KOL mapping, conference sponsorship outreach, and specialty-focused pipeline development. |
| Limitations / risks | Medium | Named current-year organizations, attendance counts, and exhibitor/sponsor rosters were not verified in the supplied source. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Higher Education; Information Technology & Services; Computer Software | Core provider, supplier, research, and digital-health targeting |
| Departments | Medical, Clinical, Research, Procurement, Supply Chain, Information Technology, Operations, Business Development, Medical Affairs | Reaches both clinical adopters and commercial decision-makers |
| Seniority | Director; VP; CXO; Head; Manager; Partner; Owner (use selectively for private specialty groups) | Prioritizes titles with budget, influence, or scientific leadership |
| Job titles | Chief of Gastroenterology, Head of Hepatology, Gastroenterologist, Hepatologist, Director of Endoscopy, Medical Director, Clinical Research Director, Principal Investigator, Procurement Manager, Supply Chain Director, Medical Affairs Director, Health IT Director | Title-led precision targeting around event themes |
| Geography | Thailand; Bangkok; Singapore; Malaysia; Indonesia; Vietnam; Philippines; broader APAC; optional global academic medical centers | Reflects likely in-person and virtual catchment |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Captures specialty clinics through large hospital systems and enterprise suppliers |
| Keywords | gastroenterology, hepatology, endoscopy, GI imaging, liver disease, NAFLD, NASH, hepatitis, IBD, microbiome, capsule endoscopy, GI oncology, transplant | Improves specialty relevance where industry data is broad |
| Technologies, if relevant | AI diagnostics, imaging analytics, EHR integration, telemedicine, research data platforms | Useful for digital health and software-led solutions |
| Revenue range, if relevant | $10M–$50M; $50M–$500M; $500M+ | Segments mid-market and enterprise healthcare organizations with buying capacity |
| Company type | Hospital system, specialty clinic, academic medical center, university, medical device manufacturer, pharma company, biotech company, health IT vendor | Supports buyer-side and partner-side segmentation |
Suggested Apollo Search Logic: (“gastroenterology” OR “hepatology” OR “endoscopy” OR “GI” OR “liver disease” OR “IBD” OR “NAFLD” OR “NASH” OR “capsule endoscopy” OR “GI oncology”) AND (Director OR Head OR Chief OR VP OR Manager) AND (Hospital OR Clinic OR Medical Center OR University OR Pharma OR Biotech OR Medical Device OR Health IT).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Gastroenterology 2026 Official Website | Official event website | Event title, date, city, country, hybrid format, theme, attendee profile, topical focus areas, and organizer claim of participation from 30+ countries | High |
| Supplied request details | User-provided event details | Venue listed as Grand Mercure Bangkok Atrium | Medium; not independently verified in the supplied official website excerpt |
| Verification note | Research constraint | No named attendee list, sponsor roster, exhibitor directory, speaker-organization list, or attendance numbers were available in the supplied official content | High confidence limitation statement |
This event is suitable for B2B attendee list building primarily through specialty-role targeting, sponsor outreach, speaker-institution mapping, and healthcare-account-based prospecting. It is less suitable for claiming a verified named attendee-company list until additional official participant data becomes publicly available.
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 4th International Conference on Advances in Gastroenterology and Hepatology — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds